Pelthos Therapeutics Inc.
PTHS
$23.06
-$0.14-0.60%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -43.32M | -23.58M | -9.04M | -7.36M | -7.96M |
| Total Depreciation and Amortization | 2.36M | 1.14M | -- | -- | -- |
| Total Amortization of Deferred Charges | 259.00K | 335.00K | 345.30K | 180.60K | 692.00K |
| Total Other Non-Cash Items | 24.18M | 6.30M | 1.58M | 1.63M | 1.44M |
| Change in Net Operating Assets | -6.07M | -1.20M | 5.18M | 1.12M | 35.00K |
| Cash from Operations | -22.59M | -17.01M | -1.93M | -4.43M | -5.79M |
| Capital Expenditure | -99.00K | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -5.14M | 2.76M | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -5.24M | 2.76M | -- | -- | -- |
| Total Debt Issued | 18.59M | 539.00K | -426.30K | 786.00K | 536.00K |
| Total Debt Repaid | -845.00K | -845.00K | -200.00 | -200.00 | -215.00K |
| Issuance of Common Stock | 206.00K | 168.00K | 83.00K | 83.00K | 6.06M |
| Repurchase of Common Stock | -- | -75.00K | -75.00K | -75.00K | -75.00K |
| Issuance of Preferred Stock | 27.38M | 27.38M | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 74.00K | -500.00 | -500.00 | -92.00K |
| Cash from Financing | 45.34M | 27.25M | -419.00K | 793.30K | 6.21M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 17.51M | 13.00M | -2.35M | -3.64M | 417.00K |